The Medical Device CROs Market Projected to be Worth USD 1.9 Billion by 2030, Predicts Roots Analysis

The Medical Device CROs Market Projected to be Worth USD 1.9 Billion by 2030, Predicts Roots Analysis

PR Newswire

LONDON, March 7, 2019

LONDON, March 7, 2019 /PRNewswire/ -- Roots Analysis has announced the addition of "Medical Device CROs Market, 2018-2030" report to its list of offerings.

Shifali Gupta, the principal analyst, stated, "Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, the opportunity for contract research providers in the medical devices domain is on the rise. Since 2000, close to 130 new CROs have been established, offering a variety of cost-efficient services and solutions to medical device developers."


The report presents opinions on several key aspects of the market. Among other elements, it includes:

It is worth mentioning that contract services for clinical operations management currently captures a relatively higher (73%) share (in terms of revenues generated) in the medical device CROs market. This trend is unlikely to change in the foreseen future. The remaining share is distributed across data management (16%), regulatory (6%) and other types of services, including consulting, quality assurance, reimbursement and post-market surveillance.

The report features inputs from a number of eminent industry stakeholders. Gupta remarked, "In recent years, there has been an evident increase in the number of clinical trials being conducted for medical devices, which has led to a greater need for outsourcing clinical stage operations. This provides opportunity for contract service providers to step in and leverage their expertise to help expedite approval timelines." The report also includes detailed transcripts of discussions held with the following experts:

The research covers detailed profiles and assesses service portfolios of several companies, including (illustrative list, no selection criteria):

For additional details, please visit: 

or email

Gaurav Chaudhary


Voltar noticias em Inglês